Detalhe da pesquisa
1.
Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension.
Br J Cancer
; 128(2): 354-362, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357702
2.
Clinical implications of germline variations for treatment outcome and drug resistance for small molecule kinase inhibitors in patients with non-small cell lung cancer.
Drug Resist Updat
; 62: 100832, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35427871
3.
Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients.
Br J Cancer
; 118(10): 1296-1301, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29695768
4.
The effect of oral vitamin K on the pre-operative reversal of vitamin K antagonists in elective noncardiac surgery.
Eur J Anaesthesiol
; 40(1): 54-74, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36409167
5.
Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies.
Oncologist
; 22(1): 33-40, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27662884
6.
p16 status and choice of chemotherapy in the KEYNOTE-040 study.
Lancet
; 394(10206): 1322-1323, 2019 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31609222
7.
Nivolumab for Squamous-Cell Cancer of Head and Neck.
N Engl J Med
; 376(6): 595-6, 2017 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28181785
8.
Review - The impact of pharmacogenetics on the outcome of immune checkpoint inhibitors.
Cancer Treat Rev
; 122: 102662, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38043396
9.
The effect of administering preprocedural VITamin K on the international normalized ratio in patients anticoagulated with ACEnocoumarol (VITKACE-study): a prospective cohort study.
J Thromb Haemost
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38580096
10.
Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYD.
Biomed Pharmacother
; 159: 114232, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630849
11.
Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1.
Clin Pharmacokinet
; 62(11): 1589-1597, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715926
12.
Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumors.
Biomed Pharmacother
; 159: 114210, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621142
13.
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies.
Drugs
; 83(2): 159-180, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36633826
14.
Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomas.
Neurooncol Adv
; 4(1): vdab177, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35047820
15.
Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial.
Clin Pharmacol Ther
; 111(2): 455-460, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34656072
16.
DPYD*7 as a Predictor of Severe Fluoropyrimidine-Related Adverse Events.
JCO Precis Oncol
; 6: e2200180, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35862869
17.
The course of C-peptide levels in patients developing diabetes during anti-PD-1 therapy.
Biomed Pharmacother
; 156: 113839, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36228374
18.
Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study.
Eur J Cancer
; 174: 113-120, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35988409
19.
UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients.
Eur J Cancer
; 162: 148-157, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34998046
20.
Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma.
Pharmaceuticals (Basel)
; 14(1)2021 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33435321